PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
06-Jan-2025 PureTech Appoints UBS as UK Corporate Broker PureTech
06-Jan-2025 AccuStem Sciences, Inc. Announces Chairman Purchase of Shares AccuStem Sciences
02-Jan-2025 Combination of Poolbeg and HOOKIPA Pharma Inc Poolbeg Pharma plc
02-Jan-2025 HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture HUTCHMED
02-Jan-2025 European Commission approves RYBREVANT®▼ (amivantamab) in combination with LAZCLUZE®▼ (lazertinib) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer Janssen-Cilag International NV
02-Jan-2025 Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines Sanofi
02-Jan-2025 CHEPLAPHARM expands Management with Tamás Szóga as VP Commercial Cheplapharm AG
02-Jan-2025 Everest Medicines Announces the Implementation of NEFECON National Reimbursement Drug List Pricing in China for the Treatment for IgA Nephropathy Everest Medicines Limited
30-Dec-2024 Change in Evolva Holding SA's shareholder structure Evolva Holding SA
30-Dec-2024 Change in Evolva Holding SA's shareholder structure Evolva Holding SA
27-Dec-2024 Relief Therapeutics Provides Update on Potential Transaction with Renexxion Relief Therapeutics Holding SA
23-Dec-2024 Abivax Announces a Change to the Composition of its Board of Directors ABIVAX
23-Dec-2024 Xlife Sciences AG Announces Potential Acquisition of Portfolio Company FUSE-AI GmbH by Pineapple Power Corporation PLC at an Expected Valuation of EUR 80-90 million Xlife Sciences AG
23-Dec-2024 Siegfried once again confirmed in the Dow Jones Sustainability Index Europe Siegfried AG
20-Dec-2024 Viromed Medical AG completes acquisition of pharmedix GmbH Viromed Medical AG
20-Dec-2024 Pedmarqsi® (anhydrous sodium thiosulfate) recommended by NICE for patients 1 month to 17 years of age in England and Wales for the prevention of cisplatin-induced hearing loss Norgine Pharmaceuticals Ltd
20-Dec-2024 Nxera Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference Nxera Pharma
20-Dec-2024 Jean-Paul Kress to join Sanofi's Board of Directors Sanofi
20-Dec-2024 Pedmarqsi® (anhydrous sodium thiosulfate) recommended by NICE for patients 1 month to 17 years of age in England and Wales for the prevention of cisplatin-induced hearing loss Norgine Pharmaceuticals Ltd
20-Dec-2024 Original-Research: Cantourage Group SE (von NuWays AG) Cantourage Group SE